Morepen Laboratories informs about audited financial results

12 May 2025 Evaluate
Morepen Laboratories has informed that the Board of Directors of the company, in their meeting held on Monday, May 12, 2025 (commenced at 11.00 am and concluded at 3.35 pm), have executed an addendum to the Business Transfer Agreement dated March 18, 2025, entered by and between the Company and Morepen Medipath (formerly known as Morepen Medtech), a subsidiary of the Company. The details as required under the SEBI Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, is given in the Annexure-A; Approved the audited standalone & consolidated financial results of the Company for the quarter and financial year ended March 31, 2025, based on the recommendation of Audit Committee. The financial results along with the report of the auditors of the company, with an unmodified opinion thereon and a declaration to that effect, are enclosed as Annexure-B; etc.

The above information is a part of company’s filings submitted to BSE.

Morepen Laboratories Share Price

42.42 -1.03 (-2.37%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×